In Brief: Abbott Serlect
Executive Summary
Abbott Serlect: NDA 20-644 for the antipsychotic agent sertindole will be discussed by FDA's Psychopharmacologic Drugs Advisory Committee July 15. On July 16, the committee will discuss the recommended modification in the frequency of required white blood cell count monitoring for Sandoz' antischizophrenic agent Clozaril (clozapine). The meeting will take place at the Holiday Inn in Silver Spring, Md., beginning at 8:30 a.m. both days...